What if the same viruses that cause the common cold could be trained to attack tumors instead of your immune system? That’s not a science fiction headline—it’s the foundation of a rapidly growing medical breakthrough known as Oncolytic Virus Immunotherapy Market. This emerging form of cancer treatment is turning heads globally, not only among researchers but also investors,...